phosphatidylcholines has been researched along with chlorethylclonidine in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (chlorethylclonidine) | Trials (chlorethylclonidine) | Recent Studies (post-2010) (chlorethylclonidine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 294 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, K; Insel, PA; Klijn, K; Slivka, SR | 1 |
1 other study(ies) available for phosphatidylcholines and chlorethylclonidine
| Article | Year |
|---|---|
Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Binding, Competitive; Cell Membrane; Clonidine; Dogs; In Vitro Techniques; Kidney; Kidney Cortex; Kidney Tubules; Phosphatidylcholines; Phosphatidylinositols; Piperazines; Prazosin; Radioligand Assay; Rats; Receptors, Adrenergic, alpha; Signal Transduction; Tissue Distribution | 1991 |